Table of Contents Author Guidelines Submit a Manuscript
International Journal of Surgical Oncology
Volume 2011 (2011), Article ID 876520, 7 pages
http://dx.doi.org/10.1155/2011/876520
Clinical Study

Retrospective Comparison of Non-Skin-Sparing Mastectomy and Skin-Sparing Mastectomy with Immediate Breast Reconstruction

1Department of Surgery, The Jikei University Kashiwa Hospital, 163-1 Kashiwashita, Kashiwa City, Chiba 277-8567, Japan
2Department of Plastic-Surgery, The Jikei University Kashiwa Hospital, 163-1 Kashiwashita, Kashiwa City, Chiba 277-8567, Japan
3Department of Breast and Endocrine Surery, The Jikei University School of Medicine, Tokyo 105-8461, Japan

Received 10 October 2010; Revised 13 May 2011; Accepted 13 June 2011

Academic Editor: Perry Shen

Copyright © 2011 Satoki Kinoshita et al. This is an open access article distributed under the Creative Commons Attribution License, which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited.

Abstract

Background. We compared Skin-sparing mastectomy (SSM) with immediate breast reconstruction and Non-skin-sparing mastectomy (NSSM), various types of incision in SSM. Method. Records of 202 consecutive breast cancer patients were reviewed retrospectively. Also in the SSM, three types of skin incision were used. Type A was a periareolar incision with a lateral extension, type B was a periareolar incision and axillary incision, and type C included straight incisions, a small elliptical incision (base line of nipple) within areolar complex and axillary incision. Results. Seventy-three SSMs and 129 NSSMs were performed. The mean follow-up was 30.0 (SSM) and 41.1 (NSSM) months. Respective values for the two groups were: mean age 47.0 and 57; seven-year cumulative local disease-free survival 92.1% and 95.2%; post operative skin necrosis 4.1% and 3.1%. In the SSM, average areolar diameter in type A & B was 35.4 mm, 43.0 mm in type C and postoperative nipple-areolar plasty was performed 61% in type A & B, 17% in type C, respectively. Conclusion. SSM for early breast cancer is associated with low morbidity and oncological safety that are as good as those of NSSM. Also in SSM, Type C is far superior as regards cost and cosmetic outcomes.